Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact

Mesothelioma Patients See Positive Results from Secondary Chemotherapy Drug

Published on June 08, 2021

Though mesothelioma researchers’ primary goal is identifying a cure for the rare and fatal form of cancer, they view any incremental progress as a positive. This week cancer researchers attending the virtual ASCO meeting heard news that UK scientists had obtained superior progression free survival in patients already treated with standard chemotherapy when they combined a secondary chemotherapy drug called vinorelbine with active supportive care.

Researchers Hear News of Superior Progression Free Survival in Mesothelioma Patients

The good news about the latest mesothelioma research was presented at the ASCO virtual meeting by Dean A. Fennell, FRCP, PhD, chair of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Trust in the UK. He reported that in a phase 2 study, vinorelbine had provided superior progression free survival for patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with malignant pleural mesothelioma eventually relapse following standard chemotherapy with pemetrexed and cisplatin. However, there is no standard treatment option in this patient setting,” he explained. “Vinorelbine exhibits useful clinical activity but has not been formally evaluated in a randomized clinical trial, despite its widespread off-label use worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study

The phase 2 trial included participation from 154 patients diagnosed with malignant pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either active support care alone or active support care combined with regular dosing of vinorelbine after having their disease progress following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months for those who did not receive the treatment. According to Fennell, the team concluded that “Vinorelbine is a safe and effective treatment and should be considered a treatment option for patients with relapsed mesothelioma.”

If you or someone you love has been diagnosed with malignant mesothelioma and you need information on treatment options, the Patient Advocates at Mesothelioma.net can help. Contact us today at 1-800-692-8608.

FREE Mesothelioma Packet

Written by Terri Oppenheimer

Terri Heimann Oppenheimer
Terri Heimann Oppenheimer is the head writer of our Mesothelioma.net news blog. She graduated from the College of William and Mary with a degree in English. Terri believes that knowledge is power and she is committed to sharing news about the impact of mesothelioma, the latest research and medical breakthroughs, and victims’ stories.

Learn more about and contact Terri
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net